• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Recurrence Rates in Uncomplicated UTIs

Opinion
Video

Panelists discuss how significant gaps in current uncomplicated urinary tract infection (UTI) therapies include insufficient nonantibiotic preventive strategies, limited options for multidrug-resistant pathogens, inadequate personalized treatment approaches, minimal focus on biofilm disruption, lack of rapid point-of-care diagnostics to guide targeted therapy, poor understanding of the urinary microbiome’s role in infection susceptibility, and insufficient research into immunomodulatory interventions that could address the underlying mechanisms of recurrence and resistance development.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
2 experts in this video
2 experts in this video
5 experts are featured in this series
5 experts are featured in this series
1 expert in this video
1 expert in this video
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.